Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

267 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal Cancer.
Dinapoli N, Barbaro B, Gatta R, Chiloiro G, Casà C, Masciocchi C, Damiani A, Boldrini L, Gambacorta MA, Dezio M, Mattiucci GC, Balducci M, van Soest J, Dekker A, Lambin P, Fiorino C, Sini C, De Cobelli F, Di Muzio N, Gumina C, Passoni P, Manfredi R, Valentini V. Dinapoli N, et al. Among authors: gambacorta ma. Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):765-774. doi: 10.1016/j.ijrobp.2018.04.065. Epub 2018 May 4. Int J Radiat Oncol Biol Phys. 2018. PMID: 29891200
Virtual simulation: fifteen years later.
Valentini V, Piermattei A, Morganti AG, Gambacorta MA, Azario L, Macchia G, Deodato F, Cilla S, Pepe D, Grimaldi L, Dinapoli N, Cellini N. Valentini V, et al. Among authors: gambacorta ma. Rays. 2003 Jul-Sep;28(3):293-8. Rays. 2003. PMID: 15018316 Review.
Chemoradiation with raltitrexed (Tomudex) in preoperative treatment of stage II-III resectable rectal cancer: a phase II study.
Gambacorta MA, Valentini V, Morganti AG, Mantini G, Miccichè F, Ratto C, Di Miceli D, Rotondi F, Alfieri S, Doglietto GB, Vargas JG, De Paoli A, Rossi C, Cellini N. Gambacorta MA, et al. Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):130-8. doi: 10.1016/j.ijrobp.2004.02.003. Int J Radiat Oncol Biol Phys. 2004. PMID: 15337548 Clinical Trial.
Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of stage II-III resectable rectal cancer: Phase I and II studies.
Gambacorta MA, Valentini V, Coco C, Morganti AG, Smaniotto D, Miccichè F, Mantini G, Barbaro B, Garcia-Vargas JE, Magistrelli P, Picciocchi A, Cellini N. Gambacorta MA, et al. Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):139-48. doi: 10.1016/j.ijrobp.2004.01.051. Int J Radiat Oncol Biol Phys. 2004. PMID: 15337549 Clinical Trial.
Biological optimization of the dose in rectal carcinoma.
Valentini V, Morganti AG, Mantini G, Petrone A, Tagliaferri L, Gambacorta MA. Valentini V, et al. Among authors: gambacorta ma. Rays. 2004 Jul-Sep;29(3):343-9. Rays. 2004. PMID: 15603308 Review.
Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM). Valentini V, et al. Among authors: gambacorta ma. Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. doi: 10.1016/j.ijrobp.2005.09.017. Epub 2006 Jan 18. Int J Radiat Oncol Biol Phys. 2006. PMID: 16414206 Clinical Trial.
267 results